What is it about?
This study includes two parts, and the first was the preparation of the Zn(II)complex by reacting N-[4-(5-{(Z)-[(5-oxo-2-sulfanyl-4,5-dihydro-1H-imidazol-1- yl)imino]methyl}furan-2-yl)phenyl]acetamide with ZnCl2. The complex was characterized by using microscopic analysis such as UV-Vis spectrum, LC-MS, FTIR spectrophotometer, measurements of conductivity, magnetic susceptibility, and atomic absorption. The second part was the preparation of the ZnO nanoparticles by dissolving the Zn(II) complex in HNO3 and HCl and its use as a drug transporter to treat leukemia. FSEM, TEM, and XRD were examined for the characterization of ZnO nanoparticles that will be used in the synthesis of most medicines and drugs in the future.
Featured Image
Why is it important?
The aim of this research is to synthesize nano-carriers that serve as carriers for the transport of leukemia drugs.
Perspectives
Writing this article was a great pleasure as it has co-authors with whom I have had long-standing collaborations. This article also lead to inorganic and nano groups contacting me and ultimately to a greater involvement in inorganic and nano research.
Areej ali jarullah
University of Diyala
Read the Original
This page is a summary of: Synthesis of ZnO Nanoparticle and Utilized as a Drug Carrier to Treat Leukemia, Indonesian Journal of Chemistry, August 2023, Universitas Gadjah Mada,
DOI: 10.22146/ijc.82208.
You can read the full text:
Contributors
The following have contributed to this page
